Friday, 9 November 2007

Will the POISE study change periop Beta Blocker use?

This discussion, from the Medscape website, gives an insight into the response that occurred at the AHA meeting in Orlando when the POISE study results where first presented (watch for the full paper in a journal soon). Chief investigator, PJ Devereaux says "I would certainly not recommend it to my mother". Experts in the discussion where divided whether beta blocker should be initiated for at risk patients presenting for high risk surgery. 

No comments:

Post a Comment